Health
New findings support current and planned clinical trials of Janssen SARS-CoV-2 vaccine – News-Medical.Net
Researchers from the United States and The Netherlands have conducted a pre-clinical study supporting the initiation of a Phase 3 trial to test a two-dose regimen…
Researchers from the United States and The Netherlands have conducted a pre-clinical study supporting the initiation of a Phase 3 trial to test a two-dose regimen of the Janssen Ad26.COV2.S vaccine candidate among adult and elderly individuals.
The team is already testing the vaccine as a single-dose regimen in a Phase 3 trial called ENSEMBLE, following its effectiveness at promoting immune responses among adult and elderly individuals in a Phase 1/2a study.
However, a further dose could potentially…
-
Noosa News11 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
Business22 hours agoWhat Warren Buffett’s latest portfolio moves say about the market
-
Business16 hours agoCounter drone company surges past $1 billion valuation with new contract win
-
Business19 hours agoBell Potter just initiated coverage with a buy recommendation for this ASX technology stock